发明名称 BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS
摘要 Optionally substituted benzoimidazol-1,2-yl amides, such as compounds of Formula 1 or Formula 2, can be used to treat disorders associated with a Kv7 potassium channel activator. Compositions, medicaments, and dosage forms related to the treatment are also disclosed herein.
申请公布号 US2016075663(A1) 申请公布日期 2016.03.17
申请号 US201514853815 申请日期 2015.09.14
申请人 Knopp Biosciences LLC 发明人 Resnick Lynn;Topalov George T.;Boyd Steven A.;Belardi Justin K.;Flentge Charles A.;Hale James S.;Harried Scott S.;Mareska David A.;Zhang Kai
分类号 C07D235/30;C07D401/04;C07D405/12;C07D413/04 主分类号 C07D235/30
代理机构 代理人
主权项 1. A compound represented by a formula: wherein D is optionally substituted C3-6 carbocyclyl, optionally substituted C2-5 heterocyclyl, isopropyl, or t-butyl; Bz is optionally substituted benzoimidazol-1,2-diyl; A is C1-8 alkyl; X is H, F, CF3, optionally substituted phenyl, or optionally substituted pyridinyl; and Y is H, F, Cl, Br, I, or a moiety having a molecular weight of 15 Da to 300 Da and consisting of 2 to 5 chemical elements, wherein the chemical elements are independently C, H, O, N, S, F, Cl, or Br.
地址 Pittsburgh PA US